心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2021 ELSO临时指南：成人心脏病患者静脉动脉体外膜肺氧合

2021-08-01 体外生命支持组织 ASAIO J

静脉动脉体外膜肺氧合

2021年8月，体外生命支持组织(ELSO)发布了成人心脏病患者静脉动脉体外膜肺氧合临时指南。

中文标题：

2021 ELSO临时指南：成人心脏病患者静脉动脉体外膜肺氧合

英文标题：

ELSO Interim Guidelines for Venoarterial Extracorporeal Membrane Oxygenation in Adult Cardiac Patients

发布机构：

体外生命支持组织

发布日期：

2021-08-01

简要介绍：

2021年8月，体外生命支持组织(ELSO)发布了成人心脏病患者静脉动脉体外膜肺氧合临时指南。本文主要讨论了成人心脏病患者静脉-动脉体外膜肺氧合(VA-ECMO)的适应证，应用方式、以及并发症的评估和治疗等。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 ELSO临时指南：成人心脏病患者静脉动脉体外膜肺氧合.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c8d561c0022051a5, title=2021 ELSO临时指南：成人心脏病患者静脉动脉体外膜肺氧合, enTitle=ELSO Interim Guidelines for Venoarterial Extracorporeal Membrane Oxygenation in Adult Cardiac Patients, guiderFrom=ASAIO J, authorId=0, author=, summary=2021年8月，体外生命支持组织(ELSO)发布了成人心脏病患者静脉动脉体外膜肺氧合临时指南。, cover=https://img.medsci.cn/20211014/1634220570988_1608702.jpg, journalId=0, articlesId=null, associationId=1101, associationName=体外生命支持组织, associationIntro=null, copyright=0, guiderPublishedTime=Sun Aug 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年8月，体外生命支持组织(ELSO)发布了成人心脏病患者静脉动脉体外膜肺氧合临时指南。本文主要讨论了成人心脏病患者静脉-动脉体外膜肺氧合(VA-ECMO)的适应证，应用方式、以及并发症的评估和治疗等。</span></p>, tagList=[TagDto(tagId=115970, tagName=静脉动脉体外膜肺氧合)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=577, guiderKeyword=心脏病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3541, appHits=98, showAppHits=0, pcHits=1653, showPcHits=3443, likes=1, shares=13, comments=4, approvalStatus=1, publishedTime=Thu Oct 14 22:21:31 CST 2021, publishedTimeString=2021-08-01, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Thu Oct 14 22:12:46 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 12:08:29 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ELSO临时指南：成人心脏病患者静脉动脉体外膜肺氧合.pdf)])
2021 ELSO临时指南：成人心脏病患者静脉动脉体外膜肺氧合.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1070901, encodeId=367110e0901bb, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d011931164, createdName=罗马帝国🐴, createdTime=Tue Nov 16 21:51:03 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060610, encodeId=3617106061056, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Oct 15 07:03:22 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060583, encodeId=8cd01060583eb, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Oct 14 23:45:13 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060582, encodeId=0b981060582d5, content=关注健康, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Thu Oct 14 23:35:31 CST 2021, time=2021-10-14, status=1, ipAttribution=)]
    2021-11-16 罗马帝国🐴

    谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1070901, encodeId=367110e0901bb, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d011931164, createdName=罗马帝国🐴, createdTime=Tue Nov 16 21:51:03 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060610, encodeId=3617106061056, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Oct 15 07:03:22 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060583, encodeId=8cd01060583eb, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Oct 14 23:45:13 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060582, encodeId=0b981060582d5, content=关注健康, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Thu Oct 14 23:35:31 CST 2021, time=2021-10-14, status=1, ipAttribution=)]
    2021-10-15 微探

    学习学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1070901, encodeId=367110e0901bb, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d011931164, createdName=罗马帝国🐴, createdTime=Tue Nov 16 21:51:03 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060610, encodeId=3617106061056, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Oct 15 07:03:22 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060583, encodeId=8cd01060583eb, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Oct 14 23:45:13 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060582, encodeId=0b981060582d5, content=关注健康, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Thu Oct 14 23:35:31 CST 2021, time=2021-10-14, status=1, ipAttribution=)]
    2021-10-14 1209e435m98(暂无昵称)

    学习了，谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1070901, encodeId=367110e0901bb, content=谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d011931164, createdName=罗马帝国🐴, createdTime=Tue Nov 16 21:51:03 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060610, encodeId=3617106061056, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Fri Oct 15 07:03:22 CST 2021, time=2021-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060583, encodeId=8cd01060583eb, content=学习了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Thu Oct 14 23:45:13 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060582, encodeId=0b981060582d5, content=关注健康, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210313/9df56058b3964a8cac82563f95f0389d/c1b478592e8e4463bef44d32712e98fd.jpg, createdBy=ea905324251, createdName=SR~young海东, createdTime=Thu Oct 14 23:35:31 CST 2021, time=2021-10-14, status=1, ipAttribution=)]
    2021-10-14 SR~young海东

    关注健康

    0

拓展阅读

2014 ACC/AAP/AHA/ASE/HRS/SCAI/SCCT/SCMR/SOPE儿童心脏病学门诊初次应用经胸廓超声心动图（TTE）检查的适用标准

美国心脏病学会(ACC,American College of Cardiology) · 2014-09-20

新生儿危重先天性心脏病术前评估中国专家共识（草案）

暂未更新 · 2017-03-30

【专题】先天性心脏病的防控，看看权威指南怎么建议

暂未更新 · 2017-05-23

2018 AHA科学声明：婴儿以及儿童心脏病患者心肺复苏

美国心脏协会(AHA,American Heart Association) · 2018-04-23

2019 ACOG实践简报：妊娠与心脏病（No.212）

美国妇产科医师学会(ACOG,American College of Obstetricians and Gynecologists) · 2019-04-25

2020 ESMO共识建议：癌症患者在肿瘤治疗过程中心脏病的管理

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2020-02-01